Association of CYP24A1 gene polymorphism with colorectal cancer in the Jiamusi population
Authors:
Open Access
- 30 June 2021
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 16 (6) , e0253474
Abstract
Background: The population in Jiamusi has been reported to have the highest prevalence of colorectal cancer (CRC) in China. The genetic causal-effect for this occurrence among the residents remains unclear. Given the long cold seasons with people wearing more clothes and reduced UV exposure, we aimed to study the association between the vitamin D metabolism-related gene CYP24A1 polymorphism and CRC susceptibility. Method: A case-control study was conducted that included 168 patients with CRC and 710 age-matched healthy individuals as the control group. Plausible susceptible variations were sought and clinical phenotypic-genotype association analysis was performed. Results: Overall, two CYP24A1 polymorphisms, rs6013905 AX (P = 0.02, OR = 1.89, 95%CI: 1.09–3.29) and rs2762939 GX (P = 0.02, OR = 1.52, 95%CI: 1.08–2.13) were significantly associated with CRC in the Jiamusi population. In the female group, three CYP24A1 polymorphisms, rs6013905 AX (P = 0.04, OR = 2.59, 95%CI: 1.03–6.49), rs2762939 GX (P = 0.01, OR = 2.35, 95%CI: 1.25–4.42), and rs6068816 GG (P = 0.05, OR = 1.89, 95%CI: 0.99–3.59) carriers were significantly associated with CRC. In clinical phenotypic-genotype analysis, rs6013905 GG (P = 0.05, OR = 4.00, 95%CI: 0.92–17.48) and rs2762939 GX (P = 0.03, OR = 4.87, 95%CI: 1.00–23.69) carriers were significantly associated with poorly differentiated CRC, while CYP24A1 rs6068816 AX was significantly associated with the tumor type (P = 0.02, OR = 2.08, 95%CI: 1.10–3.96) and location (P = 0.04, OR = 2.24, 95%CI: 1.05–4.77). Conclusion: CYP24A1 gene polymorphism may be a genetic risk factor attributable to the highest prevalence of CRC in Jiamusi people. Individuals with CYP24A1 gene polymorphism may have an increased barrier for vitamin D absorption, thus contributing to the risk of CRC development.Keywords
Funding Information
- Natural Science Foundation of China (71490732,9184910151,81849132,81400790,81460203,3176029,81571385,91849132,81872096)
- National Key Research and Development Program of China (2018YFC2000400)
- Guangxi Natural Science Foundation (2014GXNSFDA118028, 2018GXNSFAA138156, guike0991198)
- Self-funded Scientific Research Project of the health and family planning commission of Guangxi Zhuang Autonomous Region (Z20170162)
- Beijing Hospital Nova Project (BJ-2018-139)
- non-profit Central Research Institute Fund of Chinese Academy of Medical Sciences (2018RC330003)
This publication has 22 references indexed in Scilit:
- Serum Vitamin D Metabolites in Colorectal Cancer Patients Receiving Cholecalciferol Supplementation: Correlation with Polymorphisms in the Vitamin D GenesDiscover Oncology, 2013
- 25-Hydroxyvitamin D-24-hydroxylase (CYP24A1): Its important role in the degradation of vitamin DArchives of Biochemistry and Biophysics, 2012
- Early life sun exposure, vitamin D-related gene variants, and risk of non-Hodgkin lymphomaCancer Causes & Control, 2012
- CYP24A1Is an Independent Prognostic Marker of Survival in Patients with Lung AdenocarcinomaClinical Cancer Research, 2011
- Projections of the Cost of Cancer Care in the United States: 2010-2020JNCI: Journal of the National Cancer Institute, 2011
- Association of the Vitamin D Metabolism Gene CYP24A1 With Coronary Artery CalcificationArteriosclerosis, Thrombosis, and Vascular Biology, 2010
- Vitamin D pathway gene variants and prostate cancer prognosisThe Prostate, 2010
- The Candidate Oncogene CYP24A1: A Potential Biomarker for Colorectal TumorigenesisJournal of Histochemistry & Cytochemistry, 2009
- Vitamin D signalling pathways in cancer: potential for anticancer therapeuticsNature Reviews Cancer, 2007
- 25-Hydroxyvitamin D-1α-hydroxylase activity is diminished in human prostate cancer cells and is enhanced by gene transferThe Journal of Steroid Biochemistry and Molecular Biology, 2002